Branded drug from Ranbaxy gets US nod
The first branded drug from the Ranbaxy-stable in the US market, Sotret, has received approval from the US regulatory authority for the manufacture and commercialisation of the anti-acne drug in a
The first branded drug from the Ranbaxy-stable in the US market, Sotret, has received approval from the US regulatory authority for the manufacture and commercialisation of the anti-acne drug in a